China Uses Sinovac Biotech Ltd. Product for Bird Flu Vaccine Stockpile

ChinaBio Today -- The SFDA reported that it has built a stockpile of human bird flu vaccine, though it did not disclose the size of the stockpile. The vaccine, a whole virus product called Panflu, was produced by Sinovac Biotech Co., Ltd. Previously, the SFDA approved Panflu for humans aged 18 to 60 as a protective vaccine against the H5N1 virus.
MORE ON THIS TOPIC